Cita APA (7a ed.)
Weng, H., Zeng, P., Chen, Y., Xu, Q., & Ying, J. (2024, September 27). An Active Trend of Immunotherapy Combination Regimen as Second-Line Therapy Towards Advanced Biliary Tract Cancer. Clinical Medicine Insights: Oncology, 1-11.
Cita Chicago Style (17a ed.)
Weng, Haimin, Pengfei Zeng, Yuemiao Chen, Qi Xu, y Jieer Ying. "An Active Trend of Immunotherapy Combination Regimen as Second-Line Therapy Towards Advanced Biliary Tract Cancer." Clinical Medicine Insights: Oncology 27 Sep. 2024: 1-11.
Cita MLA (9a ed.)
Weng, Haimin, et al. "An Active Trend of Immunotherapy Combination Regimen as Second-Line Therapy Towards Advanced Biliary Tract Cancer." Clinical Medicine Insights: Oncology, 27 Sep. 2024, pp. 1-11.
Precaución: Estas citas no son 100% exactas.